135 related articles for article (PubMed ID: 12444976)
1. Convulxin induces platelet shape change through myosin light chain kinase and Rho kinase.
Riondino S; Gazzaniga PP; Pulcinelli FM
Eur J Biochem; 2002 Dec; 269(23):5878-84. PubMed ID: 12444976
[TBL] [Abstract][Full Text] [Related]
2. Platelet shape change is mediated by both calcium-dependent and -independent signaling pathways. Role of p160 Rho-associated coiled-coil-containing protein kinase in platelet shape change.
Paul BZ; Daniel JL; Kunapuli SP
J Biol Chem; 1999 Oct; 274(40):28293-300. PubMed ID: 10497186
[TBL] [Abstract][Full Text] [Related]
3. Involvement of a calcium-independent pathway in plasmin-induced platelet shape change.
Ishii-Watabe A; Uchida E; Mizuguchi H; Hayakawa T
Life Sci; 2001 Jul; 69(8):945-60. PubMed ID: 11488407
[TBL] [Abstract][Full Text] [Related]
4. P2X1-mediated ERK2 activation amplifies the collagen-induced platelet secretion by enhancing myosin light chain kinase activation.
Toth-Zsamboki E; Oury C; Cornelissen H; De Vos R; Vermylen J; Hoylaerts MF
J Biol Chem; 2003 Nov; 278(47):46661-7. PubMed ID: 14500714
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidic acid-induced platelet shape change proceeds via Rho/Rho kinase-mediated myosin light-chain and moesin phosphorylation.
Retzer M; Essler M
Cell Signal; 2000 Oct; 12(9-10):645-8. PubMed ID: 11080616
[TBL] [Abstract][Full Text] [Related]
6. ADP-induced platelet shape change: an investigation of the signalling pathways involved and their dependence on the method of platelet preparation.
Wilde JI; Retzer M; Siess W; Watson SP
Platelets; 2000 Aug; 11(5):286-95. PubMed ID: 11030463
[TBL] [Abstract][Full Text] [Related]
7. cGMP signaling inhibits platelet shape change through regulation of the RhoA-Rho Kinase-MLC phosphatase signaling pathway.
Aburima A; Walladbegi K; Wake JD; Naseem KM
J Thromb Haemost; 2017 Aug; 15(8):1668-1678. PubMed ID: 28509344
[TBL] [Abstract][Full Text] [Related]
8. cAMP signaling regulates platelet myosin light chain (MLC) phosphorylation and shape change through targeting the RhoA-Rho kinase-MLC phosphatase signaling pathway.
Aburima A; Wraith KS; Raslan Z; Law R; Magwenzi S; Naseem KM
Blood; 2013 Nov; 122(20):3533-45. PubMed ID: 24100445
[TBL] [Abstract][Full Text] [Related]
9. Agonist-induced regulation of myosin phosphatase activity in human platelets through activation of Rho-kinase.
Suzuki Y; Yamamoto M; Wada H; Ito M; Nakano T; Sasaki Y; Narumiya S; Shiku H; Nishikawa M
Blood; 1999 May; 93(10):3408-17. PubMed ID: 10233893
[TBL] [Abstract][Full Text] [Related]
10. Mildly oxidised low density lipoprotein induces platelet shape change via Rho-kinase-dependent phosphorylation of myosin light chain and moesin.
Retzer M; Siess W; Essler M
FEBS Lett; 2000 Jan; 466(1):70-4. PubMed ID: 10648815
[TBL] [Abstract][Full Text] [Related]
11. Dichotomous regulation of myosin phosphorylation and shape change by Rho-kinase and calcium in intact human platelets.
Bauer M; Retzer M; Wilde JI; Maschberger P; Essler M; Aepfelbacher M; Watson SP; Siess W
Blood; 1999 Sep; 94(5):1665-72. PubMed ID: 10477691
[TBL] [Abstract][Full Text] [Related]
12. Inhibition by Rho-kinase and protein kinase C of myosin phosphatase is involved in thrombin-induced shape change of megakaryocytic leukemia cell line UT-7/TPO.
Yazaki A; Tamaru S; Sasaki Y; Komatsu N; Wada H; Shiku H; Nishikawa M
Cell Signal; 2005 Mar; 17(3):321-30. PubMed ID: 15567063
[TBL] [Abstract][Full Text] [Related]
13. Thrombin-induced phosphorylation of the regulatory light chain of myosin II in cultured bovine corneal endothelial cells.
Satpathy M; Gallagher P; Lizotte-Waniewski M; Srinivas SP
Exp Eye Res; 2004 Oct; 79(4):477-86. PubMed ID: 15381032
[TBL] [Abstract][Full Text] [Related]
14. Involvement of Rho-kinase-mediated phosphorylation of myosin light chain in enhancement of cerebral vasospasm.
Sato M; Tani E; Fujikawa H; Kaibuchi K
Circ Res; 2000 Aug; 87(3):195-200. PubMed ID: 10926869
[TBL] [Abstract][Full Text] [Related]
15. Activation of G12/G13 results in shape change and Rho/Rho-kinase-mediated myosin light chain phosphorylation in mouse platelets.
Klages B; Brandt U; Simon MI; Schultz G; Offermanns S
J Cell Biol; 1999 Feb; 144(4):745-54. PubMed ID: 10037795
[TBL] [Abstract][Full Text] [Related]
16. Collagen-induced platelet shape change is not affected by positive feedback pathway inhibitors and cAMP-elevating agents.
Riondino S; Lotti LV; Cutini L; Pulcinelli FM
J Biol Chem; 2005 Feb; 280(8):6504-10. PubMed ID: 15598663
[TBL] [Abstract][Full Text] [Related]
17. Feedback Regulation of Syk by Protein Kinase C in Human Platelets.
Makhoul S; Dorschel S; Gambaryan S; Walter U; Jurk K
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31881809
[TBL] [Abstract][Full Text] [Related]
18. Evidence that the purinergic receptor P2Y12 potentiates platelet shape change by a Rho kinase-dependent mechanism.
Hardy AR; Hill DJ; Poole AW
Platelets; 2005 Nov; 16(7):415-29. PubMed ID: 16236603
[TBL] [Abstract][Full Text] [Related]
19. Essential role for class II phosphoinositide 3-kinase alpha-isoform in Ca2+-induced, Rho- and Rho kinase-dependent regulation of myosin phosphatase and contraction in isolated vascular smooth muscle cells.
Yoshioka K; Sugimoto N; Takuwa N; Takuwa Y
Mol Pharmacol; 2007 Mar; 71(3):912-20. PubMed ID: 17179444
[TBL] [Abstract][Full Text] [Related]
20. Ca2+-dependent activation of Rho and Rho kinase in membrane depolarization-induced and receptor stimulation-induced vascular smooth muscle contraction.
Sakurada S; Takuwa N; Sugimoto N; Wang Y; Seto M; Sasaki Y; Takuwa Y
Circ Res; 2003 Sep; 93(6):548-56. PubMed ID: 12919947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
